Senior VP Jennifer Leib moderated a panel discussion on Diagnostics & Personalized Medicine at the One Med Forum held in San Francisco on January 9-11th. The panel included an expert from the laboratory industry, a diagnostic company and a venture capitalist. Panelists discussed the risks and opportunities for investors as personalized medicine becomes integrated into the healthcare system. For more information, please see: http://www.onemedplace.com/forum/conference/onemedforum-sf-2012

is a government relations, public policy and strategic development firm representing clients in the dynamic new world of predictive and personalized health care. We specialize in navigating the labyrinth of legislators, regulators, health care providers, patient advocates, third-party payers, and journalists who will ultimately determine if innovation succeeds or fails.